Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia

NCT: NCT06686485 · RECRUITING

NCT IDNCT06686485
StatusRECRUITING
Start Date2025-03-18
Completion2029-10-31

Brief Summary

Subjects enrolled in the OPTION-A study will be clinically indicated for atrial fibrillation (AF) ablation procedure with the FARAPULSE™ PFA system and treatment with WATCHMAN LAAC Device, per physician's medical judgement and according to hospitals' standard of care during the same procedure.

Frequently Asked Questions

What is cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia?

cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia is a clinical trial registered under NCT06686485. Current status: RECRUITING.

What is the status of NCT06686485?

The current status of NCT06686485 (cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia) is: RECRUITING.

When did cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia start?

cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia started on 2025-03-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑